Altered phenotype of lymphatic endothelial cells induced by highly metastatic OTSCC cells contributed to the lymphatic metastasis of OTSCC cells

Cancer Science

Volumn 101, Issue 3, 2010, Pages 686-692

  Zhuang, Zhang ^a   Jian, Pan ^a   Longjiang, Li ^a   Bo, Han ^a   Wenlin, Xiao ^b  

^a SICHUAN UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CCL 7 CHEMOKINE; CHEMOKINE; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GRANULOCYTE CHEMOTACTIC PROTEIN 2; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN C;

APOPTOSIS; ARTICLE; CELL COUNT; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; LYMPH VESSEL ENDOTHELIUM; ORAL TONGUE SQUAMOUS CELL CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CXCL1; ENDOTHELIAL CELLS; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; PHENOTYPE; RECEPTORS, INTERLEUKIN-8B; TONGUE NEOPLASMS;

EID: 77949639442     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01444.x     Document Type: Article

References (39)

1. Harvey NL, Oliver G. Choose your fate: artery, vein or lymphatic vessel? Curr Opin Genet Dev 2004, 14:499-505.
2. Baldwin ME, Stacker SA, Achen MG. Molecular control of lymphangiogenesis. Bioessays 2002, 24:1030-40.
3. Pepper MS. Lymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res 2001, 7:462-8.
4. Spiro RH, Huvos AG, Wong GY, Spiro JD, Gnecco CA, Strong EW. Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg 1986, 152:345-50.
5. Myers JN, Greenberg JS, Mo V, Roberts D. Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer 2001, 92:3030-6.
6. Franchi A, Gallo O, Massi D, Baroni G, Santucci M. Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations. Cancer 2004, 101:973-8.
7. Munoz-Guerra MF, Marazuela EG, Martin-Villar E, Quintanilla M, Gamallo C. Prognostic significance of intratumoral lymphangiogenesis in squamous cell carcinoma of the oral cavity. Cancer 2004, 100:553-60.
8. Xuan M, Fang YR, Wato M, Hata S, Tanaka A. Immunohistochemical co-localization of lymphatics and blood vessels in oral squamous cell carcinomas. J Oral Pathol Med 2005, 34:334-9.
9. Clasper S, Royston D, Baban D. A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis. Cancer Res 2008, 68:7293-303.
10. Zhuang Z, Jian P, Longjiang L, Bo H, Hongwei Z. Identification of oral cancer cell-induced changes in gene expression profile of lymphatic endothelial cell. Cancer Invest 2008, 26:1002-7.
11. Zhuang Z, Jian P, Longjiang L, Bo H, Wenlin X. Oral cancer cells with different potential of lymphatic metastasis displayed distinct biologic behaviors and gene expression profiles. J Oral Pathol Med 2009, Aug 12 [Epub ahead of print]
12. Ikuta T, Ariga H, Matsumoto K. Extracellular matrix tenascin-X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation. Genes Cells 2000, 5:913-27.
13. O'Donnell RK, Kupferman M, Wei SJ. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 2005, 24:1244-51.
14. van't Veer LJ, Dai H, van de Vijver MJ. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-6.
15. Hirakawa S, Hong YK, Harvey N. Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol 2003, 162:575-86.
16. Bazarbachi A, Abou Merhi R, Gessain A. Human T-cell lymphotropic virus type I-infected cells extravasate through the endothelial barrier by a local angiogenesis-like mechanism. Cancer Res 2004, 64:2039-46.
17. Luttun A, Carmeliet P. Angiogenesis and lymphangiogenesis: highlights of the past year. Curr Opin Hematol 2004, 11:262-71.
18. Shintani S, Li C, Ishikawa T, Mihara M, Nakashiro K, Hamakawa H. Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma. Oral Oncol 2004, 40:13-20.
19. Nakayama A, Ogawa A, Fukuta Y, Kudo K. Relation between lymphatic vessel diameter and clinicopathologic parameters in squamous cell carcinomas of the oral region. Cancer 1999, 86:200-6.
20. Pepper MS, Skobe M. Lymphatic endothelium: morphological, molecular and functional properties. J Cell Biol 2003, 163:209-13.
21. Nakamura ES, Koizumi K, Kobayashi M, Saiki I. Inhibition of lymphangiogenesis-related properties of murine lymphatic endothelial cells and lymph node metastasis of lung cancer by the matrix metalloproteinase inhibitor MMI270. Cancer Sci 2004, 95:25-31.
22. Kriehuber E, Breiteneder-Geleff S, Groeger M. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med 2001, 194:797-808.
23. Mancardi S, Vecile E, Dusetti N. Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells. Immunology 2003, 108:523-30.
24. Irjala H, Alanen K, Grenman R, Heikkila P, Joensuu H, Jalkanen S. Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium. Cancer Res 2003, 63:4671-6.
25. Jackson DG, Prevo R, Clasper S, Banerji S. LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol 2001, 22:317-21.
26. Yu H, Zhou HZ, Wang CM, Gu XM, Pan BR. Effect of hepatoma H22 on lymphatic endothelium in vitro. World J Gastroenterol 2004, 10:3428-32.
27. Irigoyen M, Anso E, Martinez E, Garayoa M, Martinez-Irujo JJ, Rouzaut A. Hypoxia alters the adhesive properties of lymphatic endothelial cells. A transcriptional and functional study. Biochim Biophys Acta 2007, 1773:880-90.
28. Minn AJ, Gupta GP, Siegel PM. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436:518-24.
29. Clark EA, Golub TR, Lander ES, Hynes RO. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000, 406:532-5.
30. Achen MG, McColl BK, Stacker SA. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 2005, 7:121-7.
31. Achen MG, Stacker SA. Molecular control of lymphatic metastasis. Ann N Y Acad Sci 2008, 1131:225-34.
32. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006, 124:263-6.
33. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002, 2:563-72.
34. Loberg RD, Ying C, Craig M, Yan L, Snyder LA, Pienta KJ. CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration. Neoplasia 2007, 9:556-62.
35. Ishida T, Ueda R. CCR4 as a novel molecular target for immunotherapy of cancer. Cancer Sci 2006, 97:1139-46.
36. Rubie C, Oliveira V, Kempf K. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. Tumour Biol 2006, 27:166-74.
37. Kollmar O, Scheuer C, Menger MD, Schilling MK. Macrophage inflammatory protein-2 promotes angiogenesis, cell migration, and tumor growth in hepatic metastasis. Ann Surg Oncol 2006, 13:263-75.
38. Park JY, Park KH, Bang S. CXCL5 overexpression is associated with late stage gastric cancer. J Cancer Res Clin Oncol 2007, 133:835-40.
39. Zhu YM, Bagstaff SM, Woll PJ. Production and upregulation of granulocyte chemotactic protein-2/CXCL6 by IL-1beta and hypoxia in small cell lung cancer. Br J Cancer 2006, 94:1936-41.